Clinical Trial

Chronic Airway Disease, Mucus Rheology and Exacerbations

Study acronym: COPD-CARhE
Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this trial is to compare the exacerbation number over 12 months of follow-up between a group of patients with COPD treated according to standardized management (azithromycin prescribed in the event of severe sputum according to the CASA-Q score , standardized comparator arm) and a similar group in which azithromycin is prescribed based on mucus rheology (experimental arm) or CASA-Q.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT04339270
Lead Sponsor University Hospital, Montpellier
Collaborators: Rheonova
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 72 participants
Start Date 2023-02-03
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2024-07-16